- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01152320
Trial of Spirometry Fundamentals™ in the Primary Care Setting
Randomized Controlled Trial of Spirometry Fundamentals™ in the Primary Care Setting
Spirometry is a recommended component of asthma diagnosis and treatment in the primary care setting, yet few primary care providers report routine use of spirometry in the provision of care for their asthma patients. Misclassification of asthma severity has been reported when assessment is based on symptoms alone. This misclassification can lead to inadequate treatment that may result in increased morbidity and increased healthcare utilization/cost. However, even when spirometry is utilized to aid in asthma severity classification, primary care providers have a high rate of failing to meet the quality goals for testing established by the American Thoracic Society.
The goal of this study is to evaluate the effectiveness of the Spirometry Fundamentals™ tool in training primary care providers and their staff in producing high-quality flow-volume curves as compared to existing training modalities and to gather information in a 'real-world' setting that can be used to improve Spirometry Fundamentals™.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Currently few self-paced, distance learning programs exist that train staff to perform good quality spirometry tests. This study evaluates the effectiveness of a distance-learning tool for training primary care providers and their medical assistants in the use of spirometry to assist in managing obstructive lung disease (asthma and COPD). This tool is called "Spirometry Fundamentals™: A basic guide to lung function testing". It is a computer-based training program that teaches primary care providers and their staff what spirometry is, how it can be used, the techniques required to perform high-quality spirometry, and clinical interpretation of the spirometric data.
We evaluated the effectiveness of Spirometry Fundamentals in the primary care setting by conducting a randomized controlled trial (RCT). Study participants were primary care physicians (MDs or DOs) and their staff (medical assistants (MAs) or nurses (RNs)) and were recruited as study pairs. The role of the MDs was to utilize spirometry in clinical care by ordering spirometry tests based on their clinical judgment, and the role of the MAs was to perform the spirometry. The patients performed the spirometry as part of their usual care were not considered study subjects.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Washington
-
Seattle, Washington, Förenta staterna, 98195
- University of Washington
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Subjects must have internet access in order to transmit spirometry curve and survey data.
- Subjects must have access to a computer with Windows 2000 /Mac OS 10 or higher in order to view Spirometry Fundamentals™.
- Subjects must have access to a ndd Easyone spirometer.
Exclusion Criteria:
- Subjects who lack internet access which will be needed to transmit study data
- Subjects who lack access to a computer with Windows 2000 /Mac OS 10 or higher which will be needed to view Spirometry Fundamentals™.
- Subjects who lack access to a ndd Easyone spirometer.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Inget ingripande: Vårdstandard
|
|
Experimentell: Intervention
Spirometry Fundamentals™ CD training program
|
MD-MA pairs randomized to the intervention arm of the study received 2 copies of the Spirometry Fundamentals™ CD.
Included with the CDs was a letter explaining that each member of the MD-MA pair should view the CD at their convenience within the following 3 weeks.
This letter included instructions on how to access the study website in order to complete an evaluation survey after viewing the CD.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Spirometry test quality
Tidsram: Four months for controls; six months for intervention sites
|
Percentage of acceptable quality spirometry tests as determined by standards set by the American Thoracic Society.
|
Four months for controls; six months for intervention sites
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Effect of frequency of spirometry use on primary outcome
Tidsram: Four months for controls; six months for intervention sites
|
Examined whether frequency of spirometry use related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
Effect of practice location on primary outcome
Tidsram: Four months for controls; six months for intervention sites
|
Examined whether practice location (private/community, hospital/university) related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
Effect of practice type on primary outcome
Tidsram: Four months for controls; six months for intervention sites
|
Examined whether practice type (pediatric/non-pediatric) related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
Effect of practice structure on primary outcome
Tidsram: Four months for controls; six months for intervention sites
|
Examined whether practice structure related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
Effect of months of spirometry use on primary outcome
Tidsram: Four months for controls; six months for intervention sites
|
Examined whether months of spirometry use by practice (prior to participating in study) related to the percent of passing testing sessions conducted by the office.
|
Four months for controls; six months for intervention sites
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Rita Mangione-Smith, MD, MPH, University of Washington/Seattle Children's Hospital
- Huvudutredare: James W Stout, MD, MPH, University of Washington
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 31552-E/A
- A26829 (Annat bidrag/finansieringsnummer: American Thoracic Society)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Spirometry Fundamentals™ Training CD
-
University of CologneMedtronicOkänd
-
Medtronic Spinal and BiologicsAvslutadDegenerativ disksjukdom
-
Intec Pharma Ltd.OkändParkinsons sjukdomFörenta staterna, Spanien, Italien, Israel, Polen, Storbritannien, Bulgarien, Tyskland, Slovakien, Ukraina
-
Intec Pharma Ltd.OkändParkinsons sjukdomFörenta staterna, Israel, Italien, Spanien, Storbritannien, Bulgarien, Tyskland, Polen, Slovakien, Ukraina
-
Mutual Pharmaceutical Company, Inc.AvslutadFriska; Vuxen; Volontär; Kolchicin; Farmakokinetik; Diltiazem; Cytokrom p450 3A4; P-glykoproteinFörenta staterna